Evaluating the prophylactic use of the IL-1 antagonist anakinra to prevent neurotoxicity after CAR-T cell infusion in DLBCL patients T. Schmid, A. Heini,U. Bacher, S. Buerki, S. Messmer,S. Zeerleder,U. Novak,T. PabstSWISS MEDICAL WEEKLY(2021)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要